Adjuvant: all 21 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Labyrinthin Vaccination in Veterans With Lung AdenocarcinomaNot yet recruitingNCT07859592Phase 2
- Safety and Preliminary Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Adults Aged 18 Years and OlderNot yet recruitingNCT07807449Phase 1
- PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal CarcinomaNot yet recruitingNCT05341193Phase 1/2
- Inactivated Poliovirus Vaccine (IPV) With or Without E.Coli Double Mutant Heat-Labile Toxin (dmLT) Challenge Study in Healthy AdultsCompletedNCT04232943Phase 1Results posted
- Safety and Immunogenicity of a First-in-Human Mosquito Saliva Peptide VaccineCompletedNCT03055000Phase 1Results posted
- Clinical Trial of Subunit Influenza Vaccine (Adjuvant) in Chinese Population Aged 65 Years and OlderActive, not recruitingNCT07421050Phase 1
- Clinical Trial of Quadrivalent Subunit Influenza Vaccine (Adjuvant) in Chinese Population Aged 65 Years and OlderActive, not recruitingNCT07421037Phase 1
- Pfs230D1 + R21 in Matrix-M1 in African School Children and AdultsActive, not recruitingNCT07147400Phase 2
- A Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy AdultsActive, not recruitingNCT06442241Phase 1
- Neoadjuvant Tislelizumab in Combination With Dasatinib and Quercetin in Resectable HNSCC (COIS-01)Active, not recruitingNCT05724329Phase 2
- Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and AboveCompletedNCT05636436Phase 1
- A Study to Evaluate the Safety and Immunogenicity of H7N9 Influenza Vaccine (AT-501) in Healthy Adult SubjectsCompletedNCT02436928Phase 1/2
- Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 StudyCompletedNCT02300142Phase 2
- Dose Ranging Safety and Efficacy of Therapeutic HSV-2 VaccineCompletedNCT02114060Phase 2
- Safety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae VaccineCompletedNCT01995617Phase 1
- Influenza A Vaccine (FP-01.1) Formulated With and Without Adjuvant, in the Presence or Absence of a Single Administration of a Trivalent Inactivated Influenza Virus Vaccine in Older AdultsCompletedNCT01701752Phase 1
- Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating AdjuvantCompletedNCT01506375Phase 2
- Clinical Safety and Tolerability Study of gpASIT+TM and gpASIT+TM/Immunoregulating Adjuvant to Treat Seasonal Grass Pollen RhinoconjunctivitisCompletedNCT01111279Phase 1
- Adjuvant Hepatic Arterial Infusional Chemotherapy After Curative Resection of Hepatocellular CarcinomaCompletedNCT01088581Phase 3
- A Safety and Immunogenicity Trial With an Adjuvanted TB Subunit Vaccine (Ag85B-ESAT-6 + IC31)CompletedNCT01049282Phase 1
- Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 AdjuvantCompletedNCT00662272Phase 1